Botox use for urinary incontinence OK'd by US FDA
This article was originally published in Scrip
Executive Summary
With the US FDA's blessing to expand the product labelling for Botox (onabotulinumtoxinA) to include urinary incontinence, Allergan has once again proved that its popular selling antiwrinkle treatment is not just for cosmetic uses, but is a therapy for bona fide medical conditions.